recombinant somatropin

DRUG2 trials

Sponsors

Merck KGaA, Darmstadt, Germany, Corporacion Parc Tauli

Conditions

Infant, Small for Gestational AgePrader-Willi Syndrome

Unknown Phase

A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin)

CompletedNCT01082354

Merck KGaA, Darmstadt, GermanyInfant, Small for Gestational Age

Start: 2009-03-31End: 2015-12-31Updated: 2016-02-12

Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell

CompletedNCT02205450

Corporacion Parc TauliPrader-Willi Syndrome

Start: 2014-09-30End: 2019-07-29Updated: 2022-03-31